We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01821677
Recruitment Status : Completed
First Posted : April 1, 2013
Last Update Posted : May 5, 2016
Information provided by (Responsible Party):
Ampio Pharmaceuticals. Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2014
  Study Completion Date : January 2015